木林森(002745.SZ)子公司近日获3.5亿元政府补助
格隆汇9月21日丨木林森(002745.SZ)公布,公司下属子公司于近日收到政府补贴共计3.5亿元,其中全资子公司木林森(江西)电子有限公司获得政府补助资金9000万元;下属子公司吉安市木林森半导体材料有限公司获得政府补助资金9000万元;下属子公司吉安市木林森显示器件有限公司获得政府补助资金1.5亿元;下属子公司吉安市木林森照明器件有限公司获得政府补助资金2000万元,上述资金截止2020年9月21日已划拨至各个下属子公司的账户,系与收益相关的政府补助,于收到时确认为当期收益。该政府补助资金,不具有可持续性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.